These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 5448096)

  • 1. Melphalan and myeloma. Experience with a low-dose continuous regimen.
    McArthur JR; Athens JW; Wintrobe MM; Cartwright GE
    Ann Intern Med; 1970 May; 72(5):665-70. PubMed ID: 5448096
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term low dose melphalan treatment of multiple myeloma.
    Brook J; Bateman JR; Gocka EF; Nakamura E; Steinfeld JL
    Arch Intern Med; 1973 Apr; 131(4):545-8. PubMed ID: 4699959
    [No Abstract]   [Full Text] [Related]  

  • 3. Remission maintenance therapy for multiple myeloma.
    Arch Intern Med; 1975 Jan; 135(1):147-52. PubMed ID: 1111463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple myeloma and acute leukemia associated with alkylating agents.
    Kyle RA; Pierre RV; Bayrd ED
    Arch Intern Med; 1975 Jan; 135(1):185-92. PubMed ID: 1053891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of Kahler's disease].
    Foa J; Carcassonne Y
    Sem Hop; 1976 Jan; 52(3):165-71. PubMed ID: 186874
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of myeloma. Comparison of melphalan, chlorambucil, and azathioprine.
    Arch Intern Med; 1975 Jan; 135(1):157-62. PubMed ID: 1111464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alkeran and multiple myeloma.
    Med Lett Drugs Ther; 1966 Apr; 8(8):32. PubMed ID: 5913764
    [No Abstract]   [Full Text] [Related]  

  • 8. Multiple myeloma. II. The value of melphalan.
    Bernard DB; Lynch SR; Bothwell TH; Bezwoda WR; Stevens K; Shulman G
    S Afr Med J; 1974 May; 48(24):1026-8. PubMed ID: 4835772
    [No Abstract]   [Full Text] [Related]  

  • 9. Sequential therapy compared with combination therapy in multiple myeloma.
    Arch Intern Med; 1975 Jan; 135(1):163-71. PubMed ID: 1111465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon-alpha 2b added to melphalan-prednisone for initial and maintenance therapy in multiple myeloma. A randomized, controlled trial. The Nordic Myeloma Study Group.
    Ann Intern Med; 1996 Jan; 124(2):212-22. PubMed ID: 8533996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment for multiple myeloma. Combination chemotherapy with different melphalan dose regimens.
    Alexanian R; Haut A; Khan AU; Lane M; McKelvey EM; Migliore PJ; Stuckey WJ; Wilson HE
    JAMA; 1969 Jun; 208(9):1680-5. PubMed ID: 5818682
    [No Abstract]   [Full Text] [Related]  

  • 12. Continuous low dose of melphalan and prednisone in patients with multiple myeloma of very old age or severe associated disease.
    Pulsoni A; Villivà N; Cavalieri E; Falcucci P; La Verde G; Matera R; Petrucci MT; Tosti ME; Mandelli F
    Drugs Aging; 2002; 19(12):947-53. PubMed ID: 12495369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intermediate-dose (25mg/m2) IV melphalan for multiple myeloma with renal failure.
    Vigneau C; Ardiet C; Bret M; Laville M; Fiere D; Tranchand B; Fouque D
    J Nephrol; 2002; 15(6):684-9. PubMed ID: 12495285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone healing in multiple myeloma with melphalan chemotherapy.
    Rodriguez LH; Finkelstein JB; Shullenberger CC; Alexanian R
    Ann Intern Med; 1972 Apr; 76(4):551-6. PubMed ID: 4640313
    [No Abstract]   [Full Text] [Related]  

  • 15. [Acute leukemia in a case of multiple myeloma].
    van Hove W; Hamers J
    Ned Tijdschr Geneeskd; 1973 Sep; 117(39):1462-5. PubMed ID: 4522766
    [No Abstract]   [Full Text] [Related]  

  • 16. Toxicity in standard melphalan-prednisone therapy among myeloma patients with renal failure--a retrospective analysis and recommendations for dose adjustment.
    Carlson K; Hjorth M; Knudsen LM;
    Br J Haematol; 2005 Mar; 128(5):631-5. PubMed ID: 15725084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of melphalan and prednisone plus thalidomide in patients older than 75 years with newly diagnosed multiple myeloma: IFM 01/01 trial.
    Hulin C; Facon T; Rodon P; Pegourie B; Benboubker L; Doyen C; Dib M; Guillerm G; Salles B; Eschard JP; Lenain P; Casassus P; Azaïs I; Decaux O; Garderet L; Mathiot C; Fontan J; Lafon I; Virion JM; Moreau P
    J Clin Oncol; 2009 Aug; 27(22):3664-70. PubMed ID: 19451428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fewer bone disease events, improvement in bone remodeling, and evidence of bone healing with bortezomib plus melphalan-prednisone vs. melphalan-prednisone in the phase III VISTA trial in multiple myeloma.
    Delforge M; Terpos E; Richardson PG; Shpilberg O; Khuageva NK; Schlag R; Dimopoulos MA; Kropff M; Spicka I; Petrucci MT; Samoilova OS; Mateos MV; Magen-Nativ H; Goldschmidt H; Esseltine DL; Ricci DS; Liu K; Deraedt W; Cakana A; van de Velde H; San Miguel JF
    Eur J Haematol; 2011 May; 86(5):372-84. PubMed ID: 21366694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent overall survival benefit and no increased risk of second malignancies with bortezomib-melphalan-prednisone versus melphalan-prednisone in patients with previously untreated multiple myeloma.
    San Miguel JF; Schlag R; Khuageva NK; Dimopoulos MA; Shpilberg O; Kropff M; Spicka I; Petrucci MT; Palumbo A; Samoilova OS; Dmoszynska A; Abdulkadyrov KM; Delforge M; Jiang B; Mateos MV; Anderson KC; Esseltine DL; Liu K; Deraedt W; Cakana A; van de Velde H; Richardson PG
    J Clin Oncol; 2013 Feb; 31(4):448-55. PubMed ID: 23233713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bortezomib-melphalan-prednisone-thalidomide followed by maintenance with bortezomib-thalidomide compared with bortezomib-melphalan-prednisone for initial treatment of multiple myeloma: a randomized controlled trial.
    Palumbo A; Bringhen S; Rossi D; Cavalli M; Larocca A; Ria R; Offidani M; Patriarca F; Nozzoli C; Guglielmelli T; Benevolo G; Callea V; Baldini L; Morabito F; Grasso M; Leonardi G; Rizzo M; Falcone AP; Gottardi D; Montefusco V; Musto P; Petrucci MT; Ciccone G; Boccadoro M
    J Clin Oncol; 2010 Dec; 28(34):5101-9. PubMed ID: 20940200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.